Powering Drug Development with US – China Collaboration - BIOCOM Reception at Jones Day Shanghai Office
Organized by Jones Day, MSQ Ventures, and PharmaDJ
We are excited to announce an exclusive U.S.–China Biotech Leadership Reception taking place on April 27 at 4:30 PM to 7:00 PM on the eve of China Bio 2025.
A BIOCOM delegation of senior biotech executives will be in Shanghai to explore collaboration, licensing, and co-development opportunities in China. Participating organizations include Biocom, Balto Pharmaceuticals, Boundless Bio, 4D Molecular Therapeutics, Hexagon Bio, Ligand Pharmaceuticals, Navega Therapeutics, Neurocrine Biosciences, Tenaya Therapeutics, the University of California San Diego.
Biocom is a life sciences association in the United States, representing over 1,500 member companies across California and beyond, with a decades-long track record of advancing the U.S. biotech industry through advocacy, partnerships, and global market development.
The program will include a brief presentation on recent developments in China’s regulatory environment for CGT and small and large molecule drugs, followed by a networking reception.
Event Agenda:
4:00-4:30: Registration
4:30-5:00:
Welcome remark (Jones Day, MSQ Ventures, PharmaDJ)
Biocom delegation self introduction
Tim Scott — President & CEO
Joe Panetta — President Emeritus
Shaye Exner — Vice President, Events & Sponsorships
Balto Pharmaceuticals, Boundless Bio, 4D Molecular Therapeutics, Hexagon Bio, Ligand Pharmaceuticals, Navega Therapeutics, Neurocrine Biosciences, Tenaya Therapeutics, and the University of California San Diego.
5:00-5:30: Latest Development in China’s Regulatory Environment
From Legend to EsoBiotec: How IIT is Accelerating CGT
Dr. Dan Zhang, co-founder of ClinChoice Med Development and Hillgene Biopharma
5:30-7:00: Reception
If you are a senior leader at a China-based biotech company and would like to attend, please register via the link below. Capacity is limited and registrations will be reviewed on a rolling basis, early registration is encouraged.
We look forward to seeing you in Shanghai.
